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Abstract 
 
Background: Postoperative pain relief is often less than optimal, 
especially for those of minor surgical procedures. The objectives are to 
test the postoperative pain relief of a preoperative intravenous dose of 
40 mg tenoxicam and to investigate its tolerability and safety in 
patients undergoing minor rectal surgery. 
Methods: This study is prospective open one that included 163 patients 
with different elective & emergent ano-rectal minor conditions. The 
pain was assessed postoperatively at zero time, four, eight & 24 hours' 
time. Visual analogue scale, colour category, face description, 
postoperative mobility and verbal patient view were used to assess 
pain. The tolerability was investigated by incidence of major adverse 
event, nausea and bleeding from the operative site. The data obtained 
were processed using the statistical package of social sciences 
programme.   
Results: The study included 87 patients (53%) in the trial group and 76 
patients (47%) were in the placebo group. Patients in the trial group 
had low    measurements of postoperative pain measurements, early 
motility and more pleasure and that was statistically significant. No 
patients in the trial group had a major adverse event and all of them had 
less nausea and postoperative bleeding were less than those seen in the 
placebo group and that was statistical significant.  
Conclusion: The study recommended preoperative intravenous 
tenoxicam for patients with minor ano-rectal surgery to relieve 
postoperative pain and minimize the postoperative requirements of 
opoids.  
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 ﻣﻠﺨﺺ ﺍﻷﻃﺮﻭﺣﺔ
    
. ﺇﻥ ﺘﺨﻔﻴﻑ ﺃﻟﻡ ﻤﺎ ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ ﺍﻟﺠﺭﺍﺤﻴﺔ ﻻ ﻴﻜﺎﺩ ﻴﻜﻭﻥ ﻜﺎﻓﻴﺎﹰ ﻻ ﺴﻴﻤﺎ ﻓﻲ ﺍﻟﻌﻤﻠﻴﺎﺕ ﺍﻟﺼﻐﻴﺭﺓ :ﺨﻠﻔﻴﺔ
ﺘﻬﺩﻑ ﺍﻟﺩﺭﺍﺴﺔ ﺇﻟﻲ  .ﺘﻘﺩﻡ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺍﻷﻟﻡ ﺍﻟﺫﻱ ﻴﺘﺒﻊ ﻋﻤﻠﻴﺎﺕ ﺍﻟﺠﺭﺍﺤﺔ ﻓﻲ ﻤﻨﻁﻘﺔ ﺍﻟﻌﺠﺎﻥ ﻜﻨﻤﻭﺫﺝ
ﺩ ﺒﺩﺍﻴﺔ ﺍﻟﺘﺨﺩﻴﺭ ﻭ ﺒﺎﻟﺘﺎﻟﻲ ﺃﻴﻀﺎﹰ  ﻤﻠﻴﺠﺭﺍﻡ ﻋﻨ04ﺍﺨﺘﺒﺎﺭ ﻤﻘﺩﺭﺓ ﺠﺭﻋﺔ ﺍﻟﺘﻴﻨﻭﻜﺴﺎﻡ ﺍﻟﻭﺭﻴﺩﻴﺔ ﺒﻤﻘﺩﺍﺭ 
  .ﻗﻴﺎﺱ ﺍﻻﺘﻠﺌﺒﺎﺏ ﻋﻨﺩ ﺍﻟﻤﺭﻀﻲ ﺜﻡ ﺘﻘﻴﻴﻡ ﻭﺴﺎﺌل ﻗﻴﺎﺱ ﺍﻷﻟﻡ ﻋﻨﺩ ﺍﻟﻤﺭﻀﻲ ﺍﻟﺴﻭﺩﺍﻨﻴﻴﻥ
 ﻤﺭﻴﻀﺎﹰ ﻤﻥ ﺃﻤﺭﺍﺽ ﺍﻟﻌﺠﺎﻥ ﺍﻟﺠﺭﺍﺤﻴﺔ ﺍﻟﺨﻔﻴﻔﺔ ﺍﻟﻤﺨﺘﻠﻔﺔ ﻓﻲ 361ﺍﻋﺘﻤﺩﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ  :ﺍﻟﻭﺴﺎﺌل
ﺭ ﺍﺴﺘﻴﻌﺎﺏ ﻜﺎﻥ ﻤﺼﺩ. ﺩﻭﺍﺀ ﺼﺎﺭﻑ ﻓﺎﻋل ﻭ ﺩﺭﺍﺴﺔ ﻤﺘﻁﻭﺭﺓ ﻤﺴﺘﻘﺒﻠﻴﺔ ﻤﻀﺒﻭﻁﺔ ﺒﻭﺠﻭﺩ ﺩﻭﺍﺀ
  ﺴﻭﺒﺎ ﺍﻟﺠﺎﻤﻌﻲ ﻭﻟﻤﺤﻭﻟﺔ ﻟﻤﺭﻀﻲ ﺍﻟﻤﺴﺘﻘﻴﻡ ﻓﻲ ﻤﺴﺘﺸﻔﻲﺍﻟﻤﺭﻀﻲ ﺍﻟﺤﻭﺍﺩﺙ ﻭ ﺍﻻﺼﺎﺒﺎﺕ ﻭ ﺍﻟﻌﻴﺎﺩﺓ ﺍ
ﺍﻋﺘﻤﺩ ﺘﻘﻴﻴﻡ ﺍﻷﻟﻡ ﻋﻠﻲ ﺍﻟﺫﺍﺘﻴﺔ ﻤﻥ ﺸﻜﻭﻱ ﺸﻔﻬﻴﺔ ﻭ ﻤﻨﻅﺭ ﻭﺠﻪ .  ﺍﻟﺨﺭﻁﻭﻡ ﺍﻟﺘﻌﻤﻠﻴﻤﻲﻤﺴﺘﺸﻔﻲ
ﺍﻟﻤﺭﻴﺽ ﻭ ﺍﻟﻤﻭﻀﻭﻋﻴﺔ ﺒﻘﻴﺎﺱ ﺍﻟﻤﻨﻅﻭﺭ ﺍﻟﻤﺜﺎﻟﻲ ﻭ ﺩﺭﺠﺔ ﺘﺩﺭﺝ ﺍﻟﻠﻭﻥ ﻭ ﺯﻤﻥ ﺤﺭﻜﺔ ﺍﻟﻤﺭﻴﺽ ﺒﻌﺩ 
  .ﺘﻡ ﺘﻘﻴﻴﻡ ﺍﻟﻤﻌﻠﻭﻤﺎﺕ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺩﺍﺨل ﺍﻟﺩﺭﺍﺴﺔ ﺍﻻﺤﺼﺎﺌﻴﺔ ﺍﻟﻤﺘﻜﺎﻤﻠﺔ ﻟﻠﻌﻠﻭﻡ ﺍﻻﺠﺘﻤﺎﻋﻴﺔ. ﺍﻟﻌﻤﻠﻴﺔ
ﺃﻅﻬﺭﺕ . ﺘﻌﺎﻁﻭﺍ ﺍﻟﺼﺎﺭﻑ% 74ﻤﻥ ﺍﻟﻤﺭﻀﻲ ﺘﻌﺎﻁﻭ ﺍﻟﺩﻭﺍﺀ ﻭ % 35ﻔﺭﺕ ﺍﻟﻨﺘﺎﺌﺞ ﻋﻥ ﺃﻅ :ﺍﻟﻨﺘﺎﺌﺞ
ﻓﺼﻴﻠﺔ ﺍﻟﻌﻘﺎﺭ ﻤﻘﻴﺎﺴﺎﹰ ﺃﻗل ﻟﻸﻟﻡ ﻭ ﺤﺭﻜﺔ ﺒﺎﺩﺭﺓ ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ ﻭ ﺒﺩﻭ ﺃﻜﺜﺭ ﺭﻀﻲ ﺒﺘﺄﻜﻴﺩ ﺒﺩﺭﺠﺔ ﻋﺎﻟﻴﺔ 
ﺘﻡ ﺍﻟﺘﺄﻜﺩ ﻤﻥ ﻤﻘﻴﺎﺱ ﺍﻷﻟﻡ ﻤﺘﻭﺨﻲ ﺍﻟﺩﻗﺔ ﻓﻲ ﺍﻟﻔﺼﻴﻠﺘﻴﻥ ﺒﺎﻟﻭﺴﺎﺌل ﺍﻟﺴﺎﻟﻔﺔ .ﻤﻥ ﺍﻟﺘﺤﻠﻴل ﺍﻷﺤﺼﺎﺌﻲ
ﻴﻀﺎﹰ ﺍﻟﺘﺎﻜﺩ ﻤﻥ ﺼﻼﺤﻴﺔ ﺍﻟﻌﻘﺎﺭ ﻓﻲ ﺠﺭﻋﺔ ﺘﻤﺕ ﻤﻌﻴﺎﺭﺘﻬﺎ ﻤﻊ ﻤﻘﻴﺎﺱ ﺩﺭﺠﺔ ﺍﻟﻐﺜﻴﺎﻥ ﻭ ﺍﻟﺫﻜﺭ ﻭ ﺃ
   .ﻑ ﻭﺍﻟﺫﻱ ﺒﺩﺍ ﻤﺘﺤﺩﺍﹰ ﺍﺤﺼﺎﺌﻴﺎﹰ ﺒﻴﻥ ﻓﺼﻴﻠﺘﻲ ﺍﻟﻌﻘﺎﺭ ﻭ ﺍﻟﺼﺎﺭﻑﻴﺍﻟﻨﺯ
ﺘﻭﺼﻲ ﺍﻟﺩﺭﺍﺴﺔ ﻓﻲ ﺍﻟﺨﺘﺎﻡ ﺒﺎﺴﺘﻌﻤﺎﺭ ﺍﻟﻌﻘﺎﺭ ﺍﻟﻤﺩﺭﻭﺱ ﻟﺘﺨﻔﻴﻑ ﺍﺴﺘﻌﻤﺎل ﻤﺸﺘﻘﺎﺕ  :ﺍﻟﺨﻼﺼﺔ
ﻴﺎﻥ ﻭ ﺍﺴﺘﻌﺠﺎل ﺤﺭﻜﺔ ﻤﺭﻴﺽ ﺓ ﺍﻷﻟﻡ ﻭ ﺘﻘﻠﻴل ﺍﻟﻬﺫﺔ ﻭ ﺘﻘﺼﻴﺭ ﺤﺩﺍﻟﻤﻭﺭﻓﻴﻥ ﻓﻲ ﻓﺘﺭﺓ ﻤﺎ ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴ
  .ﺠﺭﺍﺤﺔ ﺍﻟﻌﺠﺎﻥ
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CHAPTER ONE 
          INTRODUCTION AND LITERATURE REVIEW 
1.1 Introduction 
  For a number of reasons the relief of acute pain, especially postoperative pain, 
is often less than optimal. The observation in our hospitals is that there is 
maximal care in patients with major surgical intervention, especially those who 
are nursed in the intensive therapy unit and those with thoracic or upper 
abdominal incisions. Patients with minor procedures that kept in the ward are left 
only with the usual dose of 50 mg intramuscular pethidine at full recovery. 
Patients with anal conditions are even succumbing from lack of follow up of 
their pain. In the UK, the adoption of techniques such as PCA, Patient Controlled 
Analgesia, and EOA, Epidural Opiate Analgesia, has been tempered by fears of 
severe respiratory depression and the lack of identifiable individual or group 
with the responsibility for the relief of acute pain(1). 
This situation has been compounded by a general lack of understanding of 
pharmacology and pharmacokinetics of opoids. In addition, there has been a 
failure to appreciate the potential risks of conventional intra muscular analgesia 
and psychological and physiological consequences of inadequate analgesia. In 
our set up we are in great need of preoperative analgesia to avoid the problems of 
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infrequent follow up and unnecessary delay and side effects of parentral 
administration of opioids(1). 
1.2 Pathways of Pain  
1.2.1 Pain and Nociception: The integrative action of the nervous system is still 
a mystery. What is surprising is how little the conceptual ideas about pain 
mechanisms changed over most of that period, and how much they have changed 
in the last few years.Pain appears the psychical adjunct to protective reflexes. 
Pain is envisaged as an alarm system, triggered by stimuli which threaten or 
damage the body, and drive avoidance behavior. It has been postulated that the 
existence of nociceptors, sensory neurons that would not respond to normal 
physiological events or innocuous stimuli, but would be recruited specifically by 
immediate threats (2). Researchers sought and found evidence for just such a 
population of afferent neurons, initially in skin and then in deep somatic tissues. 
It is because of the technical support in making recordings from these thin fibres 
conducting in the Ad and C range of velocities. These findings were seen as 
vindicating the so-called specificity theory, over its rival, the pattern theory 
which proposed that sensory information was encoded in a combinatorial way in 
groups of broadly tuned afferent neurons. Parenthetically, recent work on the 
properties of sensory neurons innervating visceral tissues suggests that specific 
nociceptors are very rare in many organs, and rather that noxious events are 
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mostly signaled by 'intensity-encoding' neurons that respond to innocuous 
physiological stimuli and, with a higher frequency of action potential discharge, 
to noxious ones(2). 
The idea of a specific pathway for pain was by most writers implicitly applied 
also to the central nervous system. The Gate Control theory of Melzack and Wall 
was the first serious challenge to the specific pathway theory. This theory 
emphasized that pain was a subjective experience, dependent on the context in 
which it occurred and, therefore, modifiable by other events. It is proposed that 
the activity of large diameter innocuous afferents would modify or inhibit the 
central transmission of information carried by small diameter fibers (2). 
The mechanisms of acute pain might differ substantively from those of chronic 
which are called pathophysiological pain. It is not so much that earlier facts have 
been refuted, but rather that their applicability to clinically relevant pain states 
has been challenged. What has become very clear is that the signaling system is 
itself strongly modified by the very injury that it reports upon. An informed 
consent to assess a patient is essential for mental competence of the patient and 
adequacy of information provided (3). 
This plasticity in the injury-signaling system is being intensively studied at two 
loci: firstly, at the peripheral terminals of nociceptors; secondly, at the first 
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central site of processing, in the posterior horn of the spinal cord. The changes at 
these sites are generally referred to as peripheral and central sensitization, 
respectively (2). 
Peripheral sensitization, as its name implies, relates to an increase in the 
sensitivity of the peripheral endings of nociceptors. One new development, 
however, has been the description of a novel class of nociceptors that is not 
activated by traditional noxious stimuli like excessive mechanical or thermal 
stimuli, but which is recruited when tissue becomes inflamed. These sensory 
neurons have been dubbed 'silent afferents', 'sleeping nociceptors' and, rather 
more prosaically, 'mechanically insensitive afferents'. In the presence of tissue 
injury, some of these fibers become mechanosensitive and this is likely to 
constitute an important new source of afferent barrage. Alongside traditional 
mediators such as bradykinin, prostaglandins, and serotonin, evidence is growing 
for the involvement of new molecules—cytokines and growth factors, such as 
tumor necrosis factor (TNF) and nerve growth factor (NGF) (2). 
The second major area of current interest is that of central sensitization. The 
basis of this phenomenon is that repetitive activity in unmyelinated primary 
sensory neurons is capable of producing a long-lasting facilitation in the 
responsiveness of the neurons in the spinal cord that process nociceptive 
information, which includes a lowering of the threshold of peripheral stimuli 
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necessary to excite the cells. Central sensitization appears to be a very general 
phenomenon, and has been seen in a large number of models of persistent pain 
and under a wide variety of conditions. Once recruited, however, it allows Ca2+  
to enter the postsynaptic cell, and this in turn triggers a cascade of change that 
maintains the central hyper excitable state. One of the second messengers 
activated by the increased intracellular Ca2+ levels under these conditions is 
nitric oxide (NO), a diffusible transmitter the production of which also appears to 
be critical for the development of central sensitization.  
This new knowledge is changing the emphasis of those interested in developing 
therapies to help treat patients in pain. Instead of seeking analgesic drugs which 
blocks injury-related neuronal signals at some point, there is a great opportunity 
to develop a new class of agents that are actually antihyperalgesic. Such drugs 
will hopefully restore the signaling system to its normal level of excitability.  
Therefore they retain the protective features of the pain signaling system (4). 
1.2.2 Comparison of the Dorsal Column–Medial Lemniscuses Complex with 
the Spinothalamic Path: The transmission of impulses through the dorsal 
column–medial lemniscuses pathway is subjected to a variety of control 
mechanisms. Stimulation of the sensory–motor cortex also modulates the 
transmission of impulses by both pre- and postsynaptic inhibitory mechanisms, 
and sometimes by facilitation. These descending influences are mediated by the 
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corticospinal tract. Modulation of transmission by inhibition also results from 
stimulation of the reticular formation, raphe nuclei and other sites. The dorsal 
column have been pictured as a highly reliable telephone system in which 
afferent information is separated in channels which are discrete both for spatial 
origin and stimulus specificity. In this the dorsal columns strongly contrast with 
the spinothalamic tracts (5). 
Neurons of the spinothalamic tract have very different receptive fields. 
Specificity of separate channels, as it exists in the dorsal column nuclei, is absent 
in the laminae of the cord. Convergence of different functional types of afferent 
fibers onto an individual tract cell is a common feature in the cord. On the basis 
of laminar site, functional properties and specific thalamic termination of their 
axons, spinothalamic tract neurons may be divided into three separate groups, 
namely: apical cells of the dorsal grey column, deep dorsal column cells and 
cells in the ventral grey column. 
Spinothlamic tract units project to either the ventroposterolateral (VPL) nucleus 
or to the Centrolateral nucleus of the thalamus, and sometimes to both nuclei. 
Units projecting to the ventroposterolateral nucleus receive input from all classes 
(A-b, A-d and C) of cutaneous fibers. 
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Ventral grey column spinothalamic tract cells respond mainly to deep somatic 
(muscle and joint) stimuli, but also to innocuous and/or noxious cutaneous 
stimuli. In the thoracic regions of the spinal cord they also receive convergent 
input from visceral sources. The majority of spinothalamic tract neurons have 
large, complex receptive fields (often bilateral) which encompass widespread 
areas of the body. Cells of this group that project exclusively to the medial 
thalamus receive input from A–b, A-d, and C classes of afferent fibers, and many 
respond to convergent input from receptors of deep structures. These neurons 
were found to comprise 25% wide diframic range, 63% high threshold, and 12% 
low threshold or deep type. Most of the spinothalamic tract cells in the ventral 
grey column project to the intralaminar nuclei of the thalamus (2, 4, and 6). 
The wide dynamic range type neurons are particularly effective for the 
discrimination of different intensities of painful stimulation. Furthermore, it is 
suggested that the spinothalamic projection to the ventroposterolateral nucleus is 
concerned with the discriminative aspects of pain perception, whereas the 
projection to other thalamic regions, particularly the intralaminar nuclei, may be 
involved in arousal and/or aversive behavior (2). 
The control of impulse transmission is modulated in a variety of ways. First, the 
cutaneous afferents are influenced by a tonic regulating mechanism in the 
substantia gelatinosa described previously; additionally, transmission is 
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influenced by a variety of descending fibers from the sensory–motor cortex and 
brainstem centers. 
The roles of dorsal columns and spinothalamic tracts have aroused much 
controversy (5).  
1.3 Physiology of Pain:  
There is considerable evidence that sensory stimuli are perceived in the absence 
of the cerebral cortex, and this is especially true of pain. The cortical receiving 
areas are apparently concerned with the discriminative, exact, and meaningful 
interpretation of pain, but perception alone does not require a cortex.  
1.3.1 Deep pain and adequate stimulus: The pain difference between 
superficial and deep sensibility is the different nature of the pain evoked by 
noxious stimuli. Unlike superficial pain, deep pain is poorly localized, 
nauseating and frequently associated with sweating and changes in the blood 
pressure. Pain can be elicited experimentally from the periosteum and ligaments 
by injecting hypertonic saline into them. The pain produced in this fashion 
initiates reflex contraction of nearby skeletal muscles. This reflex contraction is 
similar to the muscle spasm associated with injuries to the bones, tendons and 
joints. The steadily contracting muscles become ischemic stimulating pain 
receptors in them. The pain in turn initiates more spasm, setting up a vicious 
 9
circle (6). 
Pain receptors are specific and pain is not produced by stimulation of other 
receptors. On the other hand, the adequate stimulus for pain receptors is not as 
specific as that for others, because they can be stimulated by a variety of strong 
stimuli. For example, pain receptors respond to warmth, but it has been 
calculated that their threshold for thermal energy is over 100 times that of the 
warmth receptors. Pain receptors also respond to electrical, mechanical, and 
especially chemical energy. 
It has been suggested that pain is chemically mediated and that stimuli which 
provoke it have in common the ability to liberate a chemical agent that stimulates 
the nerve endings. The chemical agent might be a kinin or histamine, both of 
which cause pain on local injection (7). 
1.3.2 Hyperalgesia: In pathologic conditions, the sensitivity of the pain 
receptors is altered. There are two important types of alterations, primary and 
secondary hyperalgesia. In an area surrounding an inflamed or injured area, the 
threshold for pain is lowered so that the trivial stimuli cause pain. This 
phenomenon, the primary hyperalgesia, is seen around the area of the flare, the 
region of vasodilatation around the injured area. In the area of actual tissue 
damage, the vasodilatation and presumably the pain is due to substances 
liberated from injured cells, but the flare in the surrounding undamaged tissue is 
 10
due to substance P liberated by antidromic impulses in the primary afferent 
fibers. Some nerve injuries cause hyperalgesia, and these are associated with an 
increase number of substance be receptors in the spinal cord on the side of injury 
(8). 
Another aberration of sensation following injury is secondary hyperalgesia. In an 
area affected, the threshold for pain is actually elevated, but the pain produced is 
unpleasant, prolonged and severe. The area from which this response is obtained 
extends well beyond the site of injury, and the condition does not last as long as 
primary hyperalgesia. It is probably due to some sort of central facilitation by 
impulses from the injured area of the pathway responsible for the unpleasant 
affect component of pain. Such facilitation or alteration of pathways may be 
spinal subliminal fringe effect or it may occur at the thalamic or cortical level (6).   
1.4 Pain Assessment 
1.4.1 Acute Pain Service: This is to appreciate the potential risks of 
conventional intra muscular analgesia and psychological and physiological 
consequences of inadequate analgesia. This leads to the development of acute 
pain service.. The team comprises consultant anesthetist, senior pharmacist, ITU 
sister and staff nurse (1). 
The aims of this are responsibility for the day to day management of acute pain, 
organization of services to ensure that the level of care and monitoring is 
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appropriate both for clinical condition of the patient and the technique employed, 
provision of in-service training in the areas of pain assessment, principles of 
PCA and EOA, diagnosis and management of the complications and hazards of 
particular forms of treatment, audit outcomes of existing methods and evaluation 
of new techniques, giving information feedback as appropriate and clinical 
research into the relief of acute pain (1, 3). 
1.4.2 The basic idea of charting; This is considered to be suitable for use on 
any patient with acute severe pain especially postoperative pain. The drugs given 
should be written on the ‘as required and variable dose’ portion of the 
medication chart. Morphine Omnopon or Pethidine should be prescribed in doses 
related to the weight of patients. 
Prescriptions should allow one hourly administration according to instructions 
on the intramuscular analgesia flow chart.  
PRN has little meaning and its use is discouraged unless there are expectations 
of severe pain, for this it should be, but should be included together with systolic 
blood pressure (4). 
In postoperative patients, pain charts should be started in the recovery ward, and 
should accompany the patient back to the ward (9). 
Observations made by the ward staff continued on this chart including TPR and 
BP Chart 
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For the patients admitted with pain and waiting surgery, their charts should 
accompany them into the theatre with a continuous record of observations and 
treatment (base-line). 
Scores of pain assessment and sedation level are described on the observation 
chart. These should be assessed and charted along with temperature, pulse, blood 
pressure, respiratory rates (8). If pain scores are found to be 2 or 3 then follow 
instructions on the flow chart to give intramuscular analgesia. Record when 
intramuscular injection given and build up nausea score. Anti-emetics are given 
according to nausea scores and if there is nausea or vomiting (1). 
The simple chart is easy to use in practice, although less accurate for the 
research. 
The respiratory rate is counted while the patient is at rest for one minute. 
Sedation score is applied by looking for the patient and deciding: Difficult to 
waken 3, mostly sleeping 2, dozing intermittently 1 and awake  Verbal 
assessment of pain is the simpler and just an answer to questioning the patient 
‘which word describes best the pain you have now, severe, moderate, mild and 
no pain’. 
Other variety is no pain at rest and movement, slight pain on movement but no 
pain at rest, intermittent pain on rest (few problems while doing most things) A 
and moderate pain on movement (many difficulties while stopping some 
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activities considered) B and continuous pain on rest (disability with stopping 
normal activities) C and severe pain at rest (no control) D (1). Face description 
and postoperative pleasure are subjective methods and are used only in research 
with restriction (1, 9). 
 
1.4.3 VISUAL ANALOG SCALES (VAS): To allow a continuous assessment of 
pain, VAS uses a 10 cm line labeled at '0' with 'no pain' and '10' with 'worst 
pain'. The line is marked at a point corresponding to the assessment of the pain. 
The distance of the mark from zero is measured (9).   
Example of a VAS  
 
VAS has also be used to assess the severity of wounds, degree of lameness, 
activity levels.  
it has been demonstrated how VAS could be used in a field trial to show that 
pain resulting from rubber ring castration could be significantly reduced by the 
use of local anaesthesia or crushing the nerves to the scrotum and testes.  
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Videos of the lambs in the validation experiment can also be used to show that 
experience of assessing pain increased the accuracy with which individuals 
assess pain using VAS (10).    
1.4.3.1 VAS usage in Research: The VAS pain scale is a powerful research tool 
in the field of pain research. Visual analog scales are one of the most frequently 
used measurement scales in health care research. The VAS is most commonly 
known and used for measurement of pain.1, 2, 3 However; it can be used to 
measure the perception of a variety of stimuli, such as emotional distress and 
nausea4, quality of voice samples5, and recall and recognition of material in an 
educational presentation6. Despite the popularity of the VAS, it is sometimes 
misused. This is the first in a series on the visual analog scale (10).  
Visual Analog Scales measure the intensity or magnitude of sensations and 
subjective feelings, and the relative strength of attitudes and opinions about 
specific stimuli (11).  
It is important that the use of the scale be explained to each subject. The 
instruction that should be written above the scale is to put a mark on the line at 
the point that best describes how much pain the patient has at the moment. One 
should notice that what is being measured is the perception at the moment, not a 
comparison such as, what is the pain compared to what had been before.  The 
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scoring measures in millimeters from the low end of the scale to the subject 
mark. This is interval level data (12).  
1.4.3.2 VAS and Data Analysis: The reliability and validity of the scale should 
be evaluated each time it is used with a new group or situation. Reliability, 
internal consistency can be assessed by developing more than one VAS scale to 
measure the same concept but using different words; e.g. no pain at all - worst 
possible pain, intense pain - no pain. Assess test-retest reliability only if the 
variable measured is a stable trait, does not change over time, the repeat 
assessment is done within a short time interval, and the situation has not 
changed. Reliability is not assessed by asking the subject to recall an earlier 
sensation; memory is faulty. Interpreter reliability is assessing if scoring, manual 
measurement of the line is being done by more than one person; a random 
sampling of measurements can be used. Validity can be examined by using a 
different established and valid instrument, such as a verbal descriptor scale, to 
measure the same concept at the same time the VAS is used. There should be a 
high correlation between the results on the two different methods (9).  
The visual analogue pain intensity scale answers what is moderate pain in 
millimeters. One way to ensure adequate sensitivity for analgesic trials is to test 
the intervention on patients who have established pain of moderate to severe 
intensity. The usual criterion is at least moderate pain on a categorical pain 
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intensity scale. The visual analogue scales are the only pain measure in trials to 
know what point on a VAS represents moderate pain. This is if patient records a 
baseline VAS score in excess of 30 mm he has recorded at least moderate pain 
on a 4-point categorical scale (12). 
The age, sex and cause of pain are found to bear no significant difference in 
minimum clinically significant difference in VAS pain score for each of these 
variables (11). 
1.4.3.3 Other Methods of Pain Assessment: These include coloured laddered 
category and face description, both of them needs pre-designed forms. Patient's 
view on the degree of pain in simple words, satisfaction about analgesia, degree 
of activity and mobilization are subjective and used only in research (13). 
 
1.5 The pain of haemorrhoidectomy 
Ligation excision haemorrhoidectomy has a reputation of producing severe pain. 
It is the most commonly performed operation for prolapsing haemorrhoids. 
Traditionally patients have remained in hospital until the first postoperative 
bowel action, a time where parental opioids is ususlly administered (13). 
Recent trends towards earlier hospital discharge have led to re-evaluation of 
post-haemorrhoidectomy analgesia and introduction of innovative analgesic 
options. These include the use of a subcutaneous morphine pump, transdermal 
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fentanyl and intrasphincteric ketorolac administration. Regimens such as these 
have allowed haemorrhoidectomy to be performed as day surgery. However 
many of these analgesic options are expensive and require sophisticated 
equipments (14). 
 A more suitable alternative may be to use a postoperative pain management plan 
using a multimodal analgesic technique using the commonly available 
medications like simple analgesics and delivery system (15). 
Recovery from surgical haemorrhoidectomy may be very painful particularly at 
the time of the first postoperative bowel action. In this series, a wide variation of 
the postoperative pain is seen. Pain is well controlled using a multimodal 
analgesic approach. Multi-modal analgesia, a combination of two or more drugs, 
has shown benefit after surgery (15, 16). 
In particular the benefits of combining NSAIDS, local anaesthesia and opoids 
are well-recognized. The success of the pain management approach on this series 
reflected in the low mean pain scores and high level of patient satisfaction. The 
pain is expected to be higher in the second postoperative day due to the early 
analgesic effect of the pre-emptive local anesthetic block. This is thought to 
inhibit peripheral nociceptive responses and prevent altered central that amplifies 
postoperative pain (17, 18). 
Infiltration of local anaesthesia for haemorrhoidectomy is controversial. 
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Bupivacaine confers no advantage (18). Caudal injection of bupivacaine is 
superior to local injection, with patients experiencing less pain six hours after 
surgery (19). However not all patients are suitable for caudal analgesia. Failure 
rates of 5-10% and delayed ambulation have been reported. Spinal anaesthesia 
has been associated with a higher incidence of urinary retention compared with 
local infiltration (20). Lignocaine as local infiltration has a great advantage even 
when is combined with general anaesthesia to prolong analgesia (21). 
 In an effort to optimize patient advantages of early pain control in this series, 
local anaesthesia is infiltrated into the wound as well as ischiorectal fossae (22). 
The local anesthetic thus interrupts the inferior hemorrhoidal nerve and the 
perineal branch of the fourth sacral nerve on each side. It should provide 
paralysis of the external sphincter and decreased sensation in the anal canal (23). 
This is only avoided when intravenous tenoxicam is given which is proved to be 
as efficient as that in the early postoperative period (24).  
 The addition of this local block appears to confer specific advantages following 
haemorrhoidectomy, as the patients had low initial pain scores and analgesic 
requirements. (25).  
Increased pain in the fifth postoperative day is unexpected and believed to be due 
to infection; for metronidazole reduces pain on day 5 – 7 after surgery (26). 
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1.6 Tenoxicam (Tilcotil)  
Tenoxicam is thienothiazine-derivative that belongs to the chemical class of 
oxicams. The injectable form contains 0.4 mg ascorbic acid, disodium EDTA, 
mannitol, tris(hydroxymethyl)amino methane and water for injection. 
1.6.1 Effects: It has anti-inflammatory, analgesic, antipyretic properties and 
platelet inhibiting effect. It is a potent inhibitor of prostaglandin biosynthesis, 
both in vitro and in vivo. In vitro tests of leucocyte peroxidase suggest that 
tenoxicam may act as scavenger for active oxygen at the site of inflammation. 
These effects explain, at least in part, the suitable use of the drug in the treatment 
of painful, inflammatory and degenerative disorders disorders. It shows no 
mutagenic, carcinogenic or teratogenic effects in animals. As with other 
prostaglandin inhibitors, renal and gastrointestinal effects, increased incidence of 
dystocia & delayed parturition were observed in animal safety studies (27). 
1.6.2 Pharmacokinetics: On extravascular administration tenoxicam is absorbed 
in unchanged form: an oral drug is absorbed completely where as absorption 
after rectal administration is 80%. Peak plasma concentration is reached within 
two hours in fasting subjects. If it is taken orally with meals, its absorption is the 
same, but at a slower rate. 
Following the intravenous administration of 20 mg tenoxicam, the plasma levels 
decline rapidly during the first two hours mainly due to the distribution 
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processes. During this short period, there is no difference in the plasma 
concentration between the oral and intravenous routes. Following intramuscular 
administration, the levels at or above the 90% of the maximally achieved 
concentrations are reached as early as 15 minutes after a dose, this earlier than 
the oral dose. The bioavailability is complete with the muscular dose and 
indistinguishable from that administered orally. 
In the blood after 99% of the drug is bound to albumin. Tenoxicam penetrates 
well in the synovial fluid, but peak concentrations are reached later than the 
plasma.  
At the recommended dosage of 20 mg once daily, via any route, steady state 
conditions are reached within 10 - 15 days without unexpected accumulation. 
The maximum steady-state concentrations in the plasma amount to 10 -15 
microgram per ml, and did not change even on treatment for up to two years (27). 
The major part of Tenoxicam is converted to inactive metabolite 5-
hydroxypyridyl. Other metabolites occur in the form of glucuronidated 
compounds. Tenoxicam is eliminated with an average half - life of a range of 42 
to 98 hours. Up to two-thirds of the oral dosage is excreted in the urine and the 
rest in the bile. Pharmacokinetics in special situations Studies in elderly and in 
patients with renal insufficiency or liver cirrhosis suggest that no dose 
adjustment is necessary to achieve plasma concentrations similar to those in 
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healthy subjects. Because of high plasma protein binding of tenoxicam, caution 
is required when plasma albumin levels are markedly reduced as in nephrotic 
syndrome (28). 
1.6.3 Dosage & administrations: For all indications except gouty arthritis, a 
daily dosage of 20 mg should be given at the same time of day. Where indicated, 
treatment may be initiated with IV or IM 20 mg Tenoxicam for one or two days.  
Although the therapeutic effect of tenoxicam is evident early in treatment, there 
is progressive increase in response over the first two weeks until steady-state 
plasma level is reached. Daily doses higher than 20 mg should be avoided since 
this would increase the frequency and intensity of adverse reactions without 
significantly increasing efficacy. For patients needing long term treatment a 
reduction to a daily dose of 10 mg may be tried for maintenance. In principle, the 
dosage recommended also applies to elderly patients and those with kidney or 
liver disease. Because of lack of clinical experience, no dosage recommendations 
have so far being established for patients less than 18 years of age (27). 
1.6.4 Contraindications and precautions: Tenoxicam should not be 
administered to patients known to be hypersensitive to the drug. Patients in 
whom Salicylates or other NSAIDs induce symptoms of asthma, rhinitis, or 
urticaria should be avoided. This is also applied to those who have suffered or 
are suffering from upper gastrointestinal disease including gastritis, gastric and 
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duodenal ulcer. Before anaesthesia or surgery, tenoxicam, like other NSAIDs, 
should not be given to elderly patients, to patients at risk or renal failure, or to 
patients with increased risk of bleeding, because of increased risk of acute renal 
failure and possibly of impaired homeostasis(28). 
Concurrent administration of salicylates or other NSAIDs should be avoided 
because of the increased risk of gastrointestinal adverse reactions. As with other 
NSAIDs simultaneous anticoagulants and or antidiabetics should be avoided 
unless the patient is closely monitored. Prostaglandin synthetase inhibition may 
have an adverse effect on renal function. As with other NSAIDs, therefore, with 
tenoxicam, it is necessary to adequately monitor the renal function, when giving 
the drug to an elderly patient or to patient with conditions that increase their risk 
of developing renal failure such as preexisting renal disease, impaired renal 
function in diabetics, hepatic cirrhosis, congestive heart failure, volume 
depletion and concomitant treatment with diuretics or with known nephrotoxic 
potential (29).  
 
1.6.5 Undesirable effects: During clinical trials lasting from one to five days, 
the parenteral form of tenoxicam is proved to be generally tolerated in the 
recommended dose of daily 20 mg. The local tolerance is good. In patients given 
Tilcotil parentally, undesirable clinical effects or deviations from normal 
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laboratory values are usually mild and transient. These effects subsequently 
disappeared, even when treatment is continued with oral form (30). 
Tenoxicam is proved to be generally well tolerated in the recommended daily 
dose of 20 mg. The proportion of patients with undesirable clinical or laboratory 
effects is found to be around 12.5%. Only in about one percent of all patients do 
these effects necessitate interruption of treatment at 20 mg daily dose. In 
treatment lasting several weeks to three months, 11% are gastrointestinal tract 
effects in form of gastralgia, heartburn, nausea, diarrhea and constipation; rarely 
hemorrhage ulcers and perforation, three percent: central nervous system effects 
with dizziness and headache, one to two percent is skin manifestations in form of 
itching, rash, erythema and urticaria. These may be seen around the anal verge in 
rectal form of therapy (31). 
 With no exception to the non-steroidal anti-inflammatory group, very rarely, it 
can cause Steven-Johnson and Lyell syndromes. One to two percent is the renal 
effects of the drug and one to two percent is its biliary effects in form of raised 
hepatic enzymes and bilirubin. Rare miscellaneous effects include decreased 
hemoglobin, granulocytopenia, thrombocytopenia, photodermatosis and slight 
edema. Long term studies from 12 to 48 months have not revealed any increase 
in the side effects (28). 
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1.6.6 Interactions & clinical tolerability of perioperative tenoxicam: No 
interaction has been found with concomitantly administered antacids, 
probenecid, cimetidine, warfarine, and phenprocoumon at the recommended 
dosages. Salicylates displace tenoxicam from protein binding sites and thus 
increase the clearance and volume of distribution of Tenoxicam. Blood glucose 
should be monitored closely in patients on oral antidiabetics. On the other hand 
no interaction is recognized with antihypertensive. Tenoxicam is not advised in 
patients on diuretics, for the area is not yet studied (31).  
The adverse events (AEs) associated with perioperative tenoxicam shows no 
increase in the overall incidence of side effects or in major side effects. Of major 
side effects possibly or probably related to tenoxicam all but one involved 
postoperative surgical site bleeding. However, in the subgroup of patients 
undergoing otorhinolaryngology surgery, surgical site bleeding can occur. 
Endosmotically proven duodenal ulceration with malaena again is encountered in 
some studies. In general, perioperative tenoxicam is well tolerated in comparison 
with placebo in most studies and the incidence of drug-related major AEs (other 
than post-operative bleeding) is no greater than 1 in 150 in low risk patients (32). 
Dizziness, headache, tremor, somnolence, confusion, depression are recorded. 
Hallucinations, anxiety and delirium have all been attributed to NSAID, 
including tenoxicam (27), but evidence that such events were no more common 
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than in patients receiving placebo (31). Therefore neurological and psychiatric 
phenomena are not side effects of perioperative tenoxicam in relatively short 
courses. The drug neither promotes nor reduces nausea or vomiting but 
dyspepsia is more common with   tenoxicam (33).  
The post-operative bleeding at the site of surgery in patients who received 
tenoxicam is significant in patients undergoing ORL procedures and an increased 
risk of re-operation with NSAID after tonsillectomy has been identified in two 
recent systematic reviews, so this finding warrants further investigation. 
However there are significantly lower pain scores at rest and on activity in 
tenoxicam patients and a non-significant trend towards less disturbance of sleep 
because of pain (29). 
Studies of the analgesic efficacy of tenoxicam in laparoscopic, endoscopic and 
gynaecological surgery have reported potency but some adverse reactions. They 
are not placebo-controlled and involved only a single dose of tenoxicam and/or 
relatively small numbers of patients (34, 35, 36, and 37). 
The only placebo-controlled study is applied for only 68 patients that exposed to 
tenoxicam following patients for eight days after knee surgery did not report AEs 
in detail (30). 
1.6.6.1 Effect of intravenous tenoxicam during caesarean delivery on 
platelet activity: An addition of tenoxicam to the epidural block is a proved to 
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be potent analgesic (38). The effect of intravenous tenoxicam during caesarean 
delivery on skin bleeding time, operative, and postoperative blood loss, and beta-
thromboglobulin and platelet factor 4 as specific molecular markers for platelet 
activity 50% were given tenoxicam 20 mg intravenous 10 min before induction 
of general anaesthesia, and 50% formed a control group. Skin bleeding time and 
platelet markers were determined the day before and one hour after induction of 
anaesthesia. Results are in the tenoxicam group, there is good analgesia but a 
slight increase in skin bleeding time with no statistically significant changes in 
platelet marker levels. NSAIDs inhibit platelet aggregation and prolong bleeding 
time in healthy subjects, because of an inhibitory effect on cyclo-oxygenase, and 
a reduced platelet production of thromboxane A2 (39). 
An increased in uterine bleeding tendency is found to be more frequent in 
patients given preoperative tenoxicam, but with no statistical significance. This 
did not prolong the duration of operation or cause postoperative complications. 
The magnitude of this effect is similar to that seen with aspirin (40).  
 Tenoxicam is 99% bound in human plasma with a low lipophilicity due to a 
highly ionized state, which could contribute to slow onset time for analgesic 
drug effect. NSAIDs only alter bleeding time during the activity of the drug. 
However, certain members of the population are more sensitive (41).  
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 The effect of aspirin on hemostasis is more than others, so pregnant women 
could have a greater effect from tenoxicam, and this might increase bleeding 
time one hour after intravenous injection (42). 
 In late pregnancy, there is increased activation of the platelet, clotting, and 
fibrinolytic systems in vivo in addition to the observation of an increase in 
preoperative beta-thromboglobulin and platelet factor 4 levels (43).  
 The increase in platelet activation in late pregnancy appears to be physiologic 
rather than a reflection of an abnormal state or platelet activation in vitro (44).  
 Platelets may show a measurable decrease in aggregability after NSAIDs, which 
inhibit platelet cyclo-oxygenase and reduce platelet production of thromboxane 
(45).  
 It has been reported that a significant decrease in both plasma thromboxane and 
beta-thromboglobulin after treatment with 300 mg acetylsalicylic acid (46).  
 It has been demonstrated that surgery and/or intermittent positive pressure 
ventilation cause a significant rise in the level of plasma thromboxane 30 min 
after beginning of surgery and up to 24 hours after operation and the pre-
operative infusion of a loading dose of diclofenac totally abolished this increase 
(47). 
Tenoxicam before surgery antagonizes the increase in platelet marker levels. 
Tenoxicam may counteract the increased risk of thromboembolic complications 
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caused by mechanical ventilation, pelvic caesarean delivery, and the puerperium 
(48, 49). 
Studies have found that preoperative administration of small doses of NSAIDs 
versus tenoxicam does not increase blood loss after gynaecological, spine and 
transurethral prostatectomy, while full doses have been shown to increase 
intraoperative blood loss (50, 51, and 52).  
Therefore, it may be prudent to avoid the use of NSAIDs during operation in the 
presence of other defects of hamostasis or coagulation (53, 54). 
Low back pain is a common postoperative complaint after any type of 
anaesthesia. The incidence of post epidural backache after obstetric delivery is 
between 30% and 45%, (54). The incidence of immediate postoperative 
backache after non obstetric surgery is 2-31%. Postoperatively, patients 
frequently associated post epidural backache with epidural anaesthesia 
administered for the operation (55, 56).  
It is recommended the use of field-block anaesthesia to prevent post epidural 
backache, but the technique is not simple and the result is unsatisfactory. 
Conversely, systemic nonsteroidal anti-inflammatory drugs have been used 
widely to treat low back pain. Minor analgesic effects of locally applied 
NSAIDs also have been reported in animal and clinical studies. (57).  
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Prophylactic local administration of a small dose of tenoxicam 2 mg reduced 
the incidence of post epidural backache after epidural anaesthesia for 
hemorrhoidectomy (58).  
 The recommended systemic dose of tenoxicam for postoperative pain is 20-
40 mg intravenous or intramuscular every 24 hours. The local addition of 
small dose tenoxicam 2 mg is effective in reducing the incidence, duration, 
and severity of post epidural backache, particularly after multiple attempts at 
needle placement. Complications because of systemic tenoxicam 
administration are not found in this dosage (59). 
 
1.7 Surgical Perianal Pathologies 
1.7.1 Examination of the anal verge and Digital rectal examination: This 
requires careful attention to circumstances. The examining couch should be of 
sufficient height to allow easy inspection and access for any necessary man-
ouvres. A good light is mandatory. The Sim's left lateral or the lithotomy 
position are satisfactory: The latter is less convenient for an elderly patient and 
can cause social embarrassment to young women. The patient should be 
consented, relaxed and able to co-operate.  
With the buttocks opened, the anus is inspected for any lesions, e.g. 
inflammatory skin changes. Haemorrhoids, fissure, sentinel pile, fistula or 
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protruding anal tumour. The patient is asked to strain down before inspection is 
concluded. The examination is performed with the index finger. A lubricant is 
necessary. Any secretions should be sampled before applying lubricant to the 
anal verge. Extreme gentleness should be the rule so that pain is not caused. 
Painful spasm of the anal sphincters is confirmation of a hidden fissure if the 
history is suggestive  
The examination should check normal, as well as abnormal, structures according 
to the plan, intraluminally one felt feces and polyps or carcinoma may be felt, 
intramurally, normal sphincteric muscles and anorectal angle plus feeling a 
lieomyoma or carcinoma and finally extramurally one should feel for perianal 
structures and abscesses. 
At the same examination, the rectum is examined according to the same system. 
Before withdrawing the finger, the patient is asked again to strain down, and a 
note is made regarding the prostate in a male patient and the cervix, uterus and 
pouch of Douglas in a female. After withdrawal, the finger is examined for 
mucus, pus, blood and abnormal faecal material (60). 
1.7.2 Proctosigmoidoscopy: This is the examination is the rectum, the anorectal 
junction and the anal canal. The patient should also be asked to strain during 
withdrawal as by so doing an internal intussusception may be made visible. 
Minor procedures can be carried out through this instrument, e.g. treatment of 
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haemorrhoids by injection or banding and biopsy. 
Although Sigmoidoscopy is strictly an examination of the rectum and lower 
sigmoid colon, it should be carried out even when an anal lesion has been 
confirmed. Rectal pathology, e.g. colitis or carcinoma, is frequently the cause of 
an anal lesion, e.g. fissure or haemorrhoids. Not infrequently, rectal pathology is 
found that is independent of the anal lesion and which requires treatment (61). 
1.7.3 Fistula in ano 
1.7.3.1 Pathogenesis and Classification: A fistula-in-ano is a granulation tissue-lined 
track that connects the perianal skin and ano-rectum. It usually results from 
spontaneous or inadequate anorectal abscess drainage. The standard 
classification is into subcutaneous, sub mucous, low anal, high anal, and 
pelvirectal. Parks classification is based on the origin of fistula into 
intersphincteric, trans-sphincteric, high or low, and Supralevator. 
The anal Fistulae are classified according to the site of the internal opening into 
Low and high, below and above the anorectal ring respectively. The low fistula 
can be laid open without damage to the anorectal bundle; high fistula needs 
staged operations and protective colostomy. The later is to prevent septic 
complications and shorten healing time between the stages. By standard 
classification high fistulae are both a high anal & pelvirectal fistula and by 
Parks’ classification, high fistula is both high trans-sphincteric or supralevator 
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fistula. Intersphincteric is either high or low depending on what level it entered 
the anal canal. Goodsall’s rule in assessment of fistulous tract anterior to 
transverse line, fistulas have straight short track, which passes direct to the 
bowel. Fistulas have single external opening. Those posterior to transverse line, 
the common fistulae have curved tracks, and may be of the horseshoe variety. 
Fistulas have multiple external openings connected to solitary internal orifice, 
usually at midline. The transverse line is drawn across the anus. Clinical features 
include pain at defecation, persistent seropurulent discharge that causes irritation 
of the surrounding skin. Ultrasonographic or magnetic imaging is advised for 
mapping complex fistulae. Probing: has a limited value because it is painful (62). 
1.7.3.2 The management: This aims at opening the fistulous track from its 
termination to its source. A probe is inserted into the distal orifice, and 
passed until it reaches a point where no pass. The granulation tissue is 
wiped by curette and gentle probing. The edges of track are trimmed, 1-
3mm of tissue are removed for histological examination. The internal 
sphincter can be cut if necessary for intersphincteric fistula track to be laid 
open. The low-level is treated by an exploration of the track with a great 
care as the probe can be pushed through the levator ani into rectum, thus 
converting a low fistula into a high fistula. The high-level may lead to 
incontinence, so a staged operation and a coveting colostomy would be the 
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proper treatment (63). 
The supra-sphincteric fistula, occasionally inter-sphincteric, passes over the 
top of the sphincter before it passes down again in the ischiorectal fossa. An 
indwelling Seton is needed in such a case. Secondary extra-sphincteric or 
supralevator fistula is due to local disease such as Crohn’s disease, ulcerative 
colitis, carcinoma, a foreign body and trauma. The management is that of the 
underlying cause. A traumatic fistula usually needs a colostomy. None of 
these fistulae requires to be laid open, which would in any case cause 
incontinence (62, 63). 
1.7.4 Fissure in ano and benign strictures: An anal fissure is a linear tear in 
the lining of anal canal, anoderm, or it is an elongated ulcer in the long axis of 
the lower anal canal. The condition is more common in women.  
The usual site for an anal fissure is the midline posteriorly, this constitutes 90%, 
next most frequent site is the midline anteriorly. This usually originates below 
the dentate line extending to the anal verge. Cause remains unknown but here 
some certain causes of anal fissure. Incorrectly performed hemorrhoid operation; 
if too much skin is removed anal stenosis is ensued and tearing of the scar in any 
hard movement that leads to anal fissure Inflammatory bowel disease  
particularly Crohn’s disease; sexually transmitted diseases (60). 
1.7.4.1 Pathogenesis and Pathology: Acute anal fissure is a deep tear through 
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the skin of anal margin extending into the anal canal. It is associated with spasm 
of anal sphincter. Chronic anal fissure is characterized by inflamed indurated 
margins, and a classic triad that is anal ulcer, hypertrophic papilla and sentinel 
pile. Hypertrophic papilla is located at the proximal margin. Sentinel pile is a 
fibrotic external hemorrhoidal tissue at the distal fissure margin. There may be 
spasm of internal sphincter involuntary part (62, 64). 
1.7.4.2 Clinical features: Sharp burning pain starting during defecation, 
often lasting an hour or more because the fissure occurs in sensitive 
stratified epithelium of the lower half of anal canal, constipation because 
patient tends to avoid defecation and bleeding is usual. Discharge is slight 
and accompanied by pruritis. The diagnosis is based upon a typical history 
and on examination there is a sentinel skin tag can usually be displayed, 
with a tightly closed, puckered anus, is almost pathognomonic of the 
condition (64). 
1.7.4.3 The management: Treatment aim is to obtain complete relaxation 
of internal sphincter, so the fissure will slowly heal as soon as spasm has 
disappeared. Conservative treatment in acute & superficial fissure, anal 
dilator may be passed after surface local anesthetic to relax anal sphincter 
twice / day for a month, for fissure to heal. Laxatives are prescribed to 
ensure that the motions are soft, Celevac tablets give a soft stool of good 
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bulk and increased fluid intake and suppositories are not effective.  
The operative measures in chronic cases with fibrosis, skin tag, or mucous 
polyp, lateral anal sphincterotomy (75%), give local anaesthesia. Then 
internal sphincter is divided away from the fissure itself usually either in the 
right or left lateral positions. Healing is usually complete within three 
weeks. Dorsal fissurectomy and sphincterotomy is the division of the 
transverse fibres of internal sphincter in the fissure floor. Sentinel pile is 
excised if present. The after-treatment consists of attention to bowels, a 
daily Sitz bath, and the passage of an anal dilator until the wounds have 
healed, which usually takes more than three weeks (62). 
The strictures may complicate fissures. The spasmodic stricture is exemplified 
by anal fissure or rarely, accompanies a secondary megacolon, possibly due to 
chronic use of laxatives. Other examples of organic strictures those follow either 
surgery or irradiation. A postoperative stricture sometimes follows hemorr-
hoidectomy that being performed incorrectly. Low coloanal anastomoses, 
especially if a stapling gun is used, can narrow down postoperatively. Senile 
anal stenosis is a condition of chronic internal sphincter contraction is sometimes 
seen in elderly. A carcinoma should be suspected if a stricture is found, until a 
biopsy is obtained (61, 64). 
 
 36
1.7.5 Haemorrhoides 
1.7.5.1 Pathogenesis and Clinical Features: Haemorrhoids are venous 
varicosities that may be external or internal to the anal verge. External 
haemorrhoids are covered by skin, while the internal variety lies beneath the 
anal mucous membrane. The internal haemorrhoids are dilatations of the 
internal venous plexus within an enlarged displaced anal cushion due to 
communication between the internal and external plexuses. If the former 
becomes engorged, the latter is liable to become involved, The two varieties 
may be associated as interoexternal haemorrhoids.   
The internal haemorrhoids show a column of blood is unassisted by valves 
that produces high venous pressure in lower rectum, unparalleled in the 
body. They become engorged and the mucosal lining is gathered 
prominently in three anal cushions that can be in the areas of the three 
terminal branches of the superior haemorrhoidal artery. The anal cushions 
are present in embryonic life and are necessary for full continence. Straining 
causes these cushions to slide downwards and internal haemorrhoids 
develop in the prolapsing tissues.  
Symptomatic haemorrhoids may appear in carcinoma of rectum. The 
Predisposing factors include Pregnancy (48), straining at micturition induced 
by over-purgation, chronic constipation and diarrhea of enteritis, colitis, or 
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dysenteries and hereditary such as a congenital weakness of the vein walls 
or an abnormally large arterial supply to the rectal plexus. They are 
frequently arranged in three groups at 3, 7, 11 o’clock according to arterial 
supply in lithotomy position. It has the three forms a pedicled one that is 
situated at anorectal ring and covered with pale pink mucosa, another which 
commences just below the anorectal ring and covered by bright red or 
purple mucosa and an external associated skin-covered haemorrhoid that 
lies between dentate line and anal margin. The degrees of haemorrhoids are 
either first, second or three or fourth. This is according to presence of 
bleeding, bleeding and prolapse on straining with spontaneous reduction, 
bleeding and prolapse on straining with manual reduction and permanent 
prolapse (64).  
 Clinically, bright red bleeding on defecation is the earliest symptom, a 
prolapse that leads to a great discomfort, heaviness and mucoid discharge. 
Other symptoms are pruritus, pain that accompanies complications as 
abscess or anal fissure. The diagnosis depends on inspection when the 
patient strains, internal haemorrhoids may come into view transiently or, if 
they are of the third degree, they are prolapsed. Digital examination is not 
helpful unless they are thrombosed.  
 The proctoscopy and sigmoidoscopy were done to exclude higher lesions. 
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The rectal prolapse, pruritis, anorectal carcinoma, or inflammatory bowel 
disease should be excluded before a confident diagnosis is made. 
Hypertrophied anal papilla may be seen at the dentate line. They are the 
remnants of ectodermal membrane that present normally in 60% of 
examined patients as elongated anal papilla. they should not be confused 
with haemorrhoids. Elongated papillae should be excised under local 
anesthetic on the same occasion. 
1.7.5.2 Management of a patient with hemorrhoids: An advice is always 
necessary in form of bowel habit education, high-fiber diet, adequate liquid 
intake and psyllium seed product for stool softening. Patients must avoid 
straining and decrease excessive time spent on toilet. Conservativation aims 
to regulate bowel habits and ease defecation by astringent ointments and 
anesthetic creams. The injection sclerotherapy of phenol in almond 5% or 
sodium morrhuate leads to submucosal fibrosis at pile base and venous 
obliteration. Rubber-Band ligation with a Barron’s apparatus is used to 
place rubber elastic bands on the base leads to ischemic necrosis and 
sloughing of piles within few days (65).  
Cryosurgery by liquid nitrogen that expresses the extreme cold at -196˚C 
ends in coagulative necrosis of piles. Infra red Photocoagulation and the 
above-mentioned modes of treatment are for first and second degree 
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haemorrhoides. They are effective and painless. The indications for 
haemorrhoidectomy are thus failure of non-operative treatments of second 
degree haemorrhoides, fibrosis, interoexternal, third & fourth degrees. 
Preoperative preparation should be held in form of aperients, regionional 
shaving and enema. The open or closed technique involves ligation and 
excision of hemorrhoid. The anal mucosa and skin are left open to heal by 
secondary intention in the open technique while the wound is sutured in the 
closed technique.  The postoperative complications include pain, retention 
of urine and hemorrhage (64). 
 The complications of haemorrhoides are profuse hemorrhage, 
strangulation, thrombosis, ulceration, gangrene that occurs with tight, 
fibrosis following thrombosis, and suppuration and portal pyemia is 
uncommon. The strangulating piles are reduced digitally after dilating the 
anal sphincter under anaesthesia. The thrombosed and gangrenous are 
surgically excised. A severe hemorrhage due to the use of anticoagulants is 
by local adrenaline compression, morphine and blood transfusion. The 
external haemorrhoides or a perianal haematoma is called ‘a 5-day, painful, 
self-curing lesion’, is a small dot occurs in the perianal subcutaneous 
connective tissue, usually superficial to the corrugator cutis ani muscle. The 
haematoma is usually situated in a lateral region of the anal margin. It is due 
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to straining at stool, coughing, or lifting a heavy weight that increases back 
pressure on anal venule leading to rupture of a venule and perianal 
haematoma. It is tender, painful, suddenly appeared and on tense on 
examination. It is excised under local anaesthesia. The relief of pain is 
immediate and a permanent cure is certain, being left untreated, it resolves, 
fibrosed, and gives rise to a cutaneous tag (61, 64). 
1.7.6 Ano-rectal Abscesses: They are a common cause of admission to hospital, 
being more common in males and in the third decade of life. There is no 
apparent cause, but it has been suggested that infection arises in the anal gland. 
The pus tracks downwards to present as perianal abscess, outwards to form an 
ischiorectal fossa abscess and upwards to produce a high intermuscular abscess. 
An underlying cause should be sought in any recurrent abscess. 
1.7.6.1 Clinical presentation: An acute painful tender swelling with minimal 
systemic upset is the presentation of perianal abscess.  ischiorectal fossa abscess 
is painful tender swelling lateral or posterior to the anus on digital rectal 
examination with pronounced systemic signs. The uncommon intersphincteric 
abscess presents as continuous throbbing pain that exacerbated by daefecation. 
Anal discharge of pus or blood may be a complaint. Rectal examination may 
show boggy submucous tender swelling (64). 
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1.7.6.2 Management: The abscess should be drained under general anaesthesia 
through cruciate incision. Bacteriological examination and probing to exclude 
fistula are mandatory measures. If there is no fistula, the four triangles of the 
cruciate skin incision should be excised to deroof the cavity. 
1.7.7 Lower Rectal and Anal Neoplasms 
1.7.7.1 Benign Tumours: Polyps are elevations of the mucosal surface in the 
rectosigmoid and decending colon in 65% of cases. They are either sessile with 
broad base or pedunculated with a holding stalk. Their incidence is 25% for 
patients older than 60 years. Hyperplastic, hamartomatous and inflammatory 
polyps have no malignant potential while the adenomatous polyps have. They 
present with rectal bleeding or positive faecal occult blood and confirmed by 
sigmoidoscopic or colonoscopic examination (66). 
Anal papillomata either warts or condylomata acuminata are multiple sessile or 
pedunculated friable lesions due to viral infection or immunosuppression in the 
perianal area. Their presentation is irritating bloody discharge. Local application 
of podophyllin, excision or diathermy and interferon are the known modalities of 
treatment. 
1.7.7.2 Malignant Tumours: Although carcinoma of the rectum is 50 times 
more common, this accounts for about 50 percent of malignant anal growth. 
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Localized ulcer, profuse discharge, incontinence anal stenosis or indurations, 
inguinal lymphadenopathy are the possible presentations. 
Biopsy as minor procedure should be obtained to confirm the diagnosis of 
colorectal cancer on screening surveillance and suspected cases. If excision is 
feasible, abdomioperineal resection is done. Radical radiotherapy is an adjuvant, 
palliative or alternative (67).  
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CHAPTER TWO 
OBJECTIVES & METHODOLOGY 
2.1 The objectives 
 
a) To determine efficacy of preoperative intravenous tenoxicam in 
postoperative pain relief in patients having minor ano-rectal operative 
procedure. 
b) To determine the tolerability and safety of the drug in these patients. 
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2.2 Patients and Methods 
 
This is a prospective, multicentric, open study which was conducted in the 
period between august 2005 and October 2006. The study included 163 
Sudanese patients with ano-rectal conditions who underwent examination just 
before anaesthesia and / or surgical intervention as elective or emergency at Soba 
University and Khartoum Teaching Hospitals. 
The exclusion criteria of this study included American Society of 
Anesthiologists (ASA) Grade 4 and 5, patients less than 16 years old, patients 
with asthma, bleeding tendency, symptoms of bladder outlet obstruction, peptic 
ulcer disease, chronic renal problems, blindness or motor or sensory neurological 
deficit and pregnant ladies. 
Informed consent was obtained from each patient after a preoperative discussion 
and explanation of the study. This is mandatory for patient co-operation and 
relaxation (13).  
The patient's personal information was collected in a pre-designed questionnaire. 
It included name, age, gender, residence, occupation, socioeconomic status, 
marital status and educational level. There was especial emphasis on history of 
previous ano-rectal or other surgeries, the diagnosis, the clinical type of surgery 
and anaesthesia, surgeon grade and the operative time. (Plate No.1) 
 The pulse, blood pressure and respiratory rate were measured and recorded on 
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the day before surgery and postoperatively at the recovery room (zero time), 4, 8 
and 24 hours. 
Temperature below 38oC was considered as normal, between 38oC and 39oC as 
moderately elevated and above 39oC as high. Pulse of 80/min or less was 
considered as normal, between 80/min and 90/min as moderately rapid and 
above 90/min as markedly rapid. The respiratory rate up to 16/min was 
considered as normal, between 16 and 18/min as moderately increased and above 
18 as markedly increased.  Systolic pressure of 130 mmHg or less was 
considered as normal, between 130 and 145 mmHg as moderately raised and 
above 145 mmHg as high (6, 9 ).  
The patients were randomized by an anaesthetic assistant into two groups, the 
placebo group that received intravenous 50 mg hydrocortisone in 4 ml normal 
saline and trial group that received intravenous 40 mg tilcotil in 4 ml volume. 
This subphysiological dose was used because it has the same optic density to the 
tested drug. This was measured using spectrophotometer. Patients of the trial 
group were labelled as T group, and those who were given the placebo as P 
group. Two mg of tenoxicam were given intra-dermally to test for drug 
hypersensitivity before giving the drug intravenously. No patient had local 
anesthetic in this study as this blocks the peripheral sensation and later it 
magnifies postoperative pain, especially in the second postoperative day (16).  
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Every patient was advised to take oral paracetamol up to one gram every eight 
hours and if needed pethidine sulphate was given in an appropriate dose (17). 
In this study, the postoperative pain was assessed using visual analogue scale, 
verbal comment, laddered colour category and face description in the recovery 
room (zero time), at 4, 8 and 24 hours postoperatively.  
The visual analogue scale is a printed horizontal line 100 mm long. It was used 
without gradation to avoid reducing its sensitivity. The measurements of visual 
analogue scale were done by a single transparent ruler used for manual scoring 
all the time. Scores of 70 mm or more were considered as severe pain and those 
from 31 mm to 69 mm as moderate pain (Plate No.2). Patients were asked by the 
limited number of staff to mark their pain on the VAS line. This was to reduce 
the interpersonal effect between the interviewer and patient, particularly if there 
is a change of staff and one rating was not allowed to be a reference point for the 
next rating to eliminate response bias (68). 
Patients were asked to describe their pain. This was taken as verbal comment and 
filled in a space provided in a pre-designed table in the questionnaire paper as no 
pain, mild, quite bad or moderate, very bad or severe.(Plate No.1)  
Patients were offered a coloured ladder to tick on the pain level they had, Green, 
yellow, orange or red. (Plate No.2) (69). 
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The degree of postoperative mobility was assessed and classified as follows; few 
problems while doing most things considered as class A, many difficulties while 
stopping some activities considered as class B, disability with stopping normal 
activities considered as class C and no control on their activities considered as 
class D (1,11). (Plate No.2 & Table No.11) 
A face presentation compared according to the pre-designed figures, ranging 
from A which was normal face, B, C to D which was apprehensive very ill face 
(68). (Plate No.3) 
Pain management was not delayed or withheld by participation in this study. 
Interviews and data collection were performed by the researcher or staff member 
who were not aware of the clinical management of the patients (69). 
Postoperative nausea and sedation were reported at 24 hours postoperatively. 
The degree of postoperative site bleeding was classified as minimal that wetted 
underwear, moderate that is associated with systemic symptoms (cold 
extremities, sweating &/or dizziness) and required a change of dressing and 
severe that required the administration of intravenous fluid or blood.   
Postoperative satisfaction and pleasure were assessed at 24 hours postoperatively 
after giving him five options to choose to minimize the risk of inability to 
express. These were very unsatisfactory (The very worst quality), unsatisfactory 
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(Poor or not good enough), satisfactory (Expectations were acceptable), pleased 
(Willing and glad) and very pleased (The very best quality). (Table No.10) (13). 
The statistical package of social sciences (SPSS) program, version 13, by (NDF 
Company) was used to analyze the obtained data. The Pearson Chi-Square test 
was used when appropriate. P values of less than 0.05 were considered as 
statistically significant. 
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CHAPTER THREE 
3 Results 
  The study included 163 adult Sudanese patients with ano-rectal conditions. It 
was conducted in the period between August 2005 to November 2006 at Soba 
University and Khartoum Teaching Hospitals. The study group included 
emergency and elective cases. Eighty-seven patients (54%) were admitted from 
the outpatient clinics and 76 patients (46%) from accident and emergency 
department (Fig.1, Table 3). There were 111 male patients (68%) and  52 
patients were females(32%)  (Fig.2). Their ages ranged from 14 to 65 years with 
the mean age of (29 + 6). Ninety-nine patients (60%) were single and 64 of them 
were married. The study group included 87 patients (53%) in the trial group and 
76 patients (47%) in the placebo group.  
There were 52 patients (31.9%) from Khartoum State, 46 patients (28.2%) from 
Gezira State, 21 patients (12.9%) from the Western Sudan and the remaining 44 
patients (27%) was from Northern & Eastern Sudan. They were from different 
tribal origins. Most of the patients were labourers.  (Fig.3). 
 With regards to their educational level, 55% of them had the intermediate 
education or less (Table.1). The majority of patients (85%) were either of low or 
moderate socioeconomic classes (Fig.4).  
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Ninety-one patients (56%) had no history of previous surgery, 64 patients (39%) 
had one operation before and only eight patients (5%) had more than one 
operation (Fig.5).   
All patients were seen, examined and diagnosed by a consultant or a surgical 
registrar before surgery. Fifty-nine patients (36%) had fissure in ano either acute 
or chronic. Twenty-eight patients (17 %) had fistula in ano and that included 
recurrent disease, multiple fistulae and pus collection in a fistulous tract. 
Twenty-five patients (15.5%) had haemorrhoides in the form of external, third 
degree, recurrent, thrombosed or prolapsed haemorrhoides. Seventeen patients 
(10%) had perianal or submucous abscesses. In the study 68 patients (17%) had 
rectal bleeding due to prolapse, polyps and low rectal or anal tumors (Table 2).  
Pain assessment using visual analogue scale at zero time was below 70 mm in 84 
patients (96.5 %) in the trial group compared with 71 patients (93.4%) in the 
placebo group. This was not statistically significant, P value = 0.202 (Table 4). 
The postoperative pain measurements at eight hours were below 70 mm in 85 
patients (97.7%) in the trial group compared with 68 patients (89.5%) in the 
placebo group. This was statistically significant, P value = 0.0001 (Table 5). The 
pain measurements at 24 hours postoperatively were below 30 mm in 81 patients 
(93.1%) in the trial group compared with 50 patients (65.8%) in the placebo 
group. This was statistically significant, P value = 0.0001   (Table 6). 
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Subjective measures of postoperative pain assessment at 24 hours were used and 
that included colour category. Green colour was chosen by 81 patients (93.1%) 
in the trial group compared with 31 patients (40.8%) in the placebo group. This 
was considered statistically significant, P value = 0.0001   (Table 7).  
Fifty-one patients (57.5%) in the trial group 24 hours following surgery had 
normally looking face compared with 25 patients (32.9%) in the placebo group. 
This was statistically significant, P value = 0.0001   (Table 8). 
Minimal pain was used to describe the pain by 64 patients (73.5%) in the trial 
group compared with 29 patients (38.2%) in the placebo group. This was 
statistically significant, P value = 0.0001   (Table 9). 
Forty-six patients (52.9%) in the trial group had the best satisfaction 24 hours 
postoperatively compared with only five patients (6.6%) in the placebo group. 
This was statistically significant, P value = 0.0001   (Table 10). 
Regarding postoperative motility, the study showed mobility of A and B degrees 
was more in the trial (74.7% of patients) compared with the placebo group 
(57.9% of patients),  but  this difference was not statistically significant, P value 
= 0.668. (Table 11). 
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The drug was tolerated by the patients since nobody developed a major adverse 
effect.  There was significant difference between the two groups of patients with 
regards to nausea and the degree of post operative bleeding. (P value = 0.013, 
statistically significant) (Table12&13). 
Postoperative nausea was reported in 37 patients (42.5%) in the trial group 
compared with 64 patients (84.2%) in the placebo. That is statistically 
significant, P values = 0.0001.  
There was increase of analgesic doses of pethidine sulphate and sedation in the 
placebo group compared to the trial group and that was statistically significant, P 
values = 0.0001 (Table14 & 15).  
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CHAPTER FOUR 
4.1 Discussion 
 
The present study tested the use of intravenous tenoxicam for postoperative 
pain relief in 163 Sudanese patients with minor colorectal conditions. It 
proved to be efficient in relief of postoperative pain using VAS 
measurements, color category, face presentation, postoperative mobility and 
satisfaction. This is in line with what was reported by Limb who found that 
intravenous tenoxicam was as efficient as local anaesthetic infiltration in the 
early posthaemorrhoidectomy pain (24).  
This is also in line with other authors who tested the analgesic efficacy of 
tenoxicam following different operations. The examples include Wilkinson 
who tested the intrathecal admininstration of 2 mg with spinal anaesthesia or 
intravenous 40 mg of tenoxicam to abolish postoperative backache following 
hemorrhoidectomy or epidural block (57), Flhakim who studied the effects of 
intravenous tenoxicam following caesarean section(37) and Eggers who studied 
the analgesic effect of intravenous tenoxicam in patients with knee 
replacement(5)  
The postoperative mobility of patients in the trial group was earlier than those in 
the placebo group. This was statistically insignificant. This was commonly seen 
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in patients with previous surgery. Therefore this may be these patients had 
passed this experience before and able to overcome the fear of surgery. This in 
line with that reported by Gabrielli(20). In this study patients with fissure in ano 
and no history of previous operation had delayed postoperative mobility. High 
pain scores were seen in patients with high socio-economic status and anorectal 
abscesses (Fig.5&9).  This is more in line with what was reported with Deckler 
(29). Postoperative mobility is a subjective measure and could be due to 
inadequate patients’ counseling, type of surgical procedure and type of 
anaesthesia.  
Rang (27) reported increased incidence of more nausea in patients in the trial 
group than in the placebo group. The present study shows higher incidence of 
nausea in the placebo group compared with the trial group. Patients in the 
placebo group received more pethidine sulphate which and the nausea may be 
attributed to it, because it is dose-related. Twelve patients (13.7%) in the trial 
group were given pethidine sulphate 25 mg and all of them had nausea.  
 Alan(33) reported no nausea but more dyspepsia with the drug.   No patient in the 
study group had dyspeptic symptoms. The mean age of patients in this study is 
29 years and that of his is 44 years, so the difference is probably age-related.  
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Tenoxicam has major adverse side effects such as gastric bleeding, renal 
impairment, or increased bleeding, caused by inhibition of platelet activity. 
However none of these side effects were observed in this study.  
No patient experienced a gastrointestinal bleeding, neurological manifestation or 
hypersensitivity. This is in line with what was reported by Eggers who did only 
placebo-controlled study to test postoperative adverse effects of tenoxicam and 
not in line with Alan who reported one patient of 1001 patients presenting with 
gastric ulceration with malaena. . This was confirmed by endoscopic 
examination Alan’s study is not randomized and Eggers’ study group and ours 
are small to test for the major side effects of the drug (30).  
Jones (37) reported a case of renal impairment following preoperative tenoxicam 
in a patient who underwent total abdominal hysterectomy and heintz (28) reported 
renal impairment, for this reason we had excluded patients with renal problems.  
Although Flhakim (39), Cohen (48) and Marret (32) reported an increased incidence 
of bleeding with the usage of intravenous tenoxicam in caesarean section and 
tonsillectomy, the present study demonstrates that tenoxicam had no effect on 
postoperative bleeding following minor ano-rectal surgeries compared with the 
placebo group.  
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The increase of bleeding time reported by them one hour after intravenous 
tenoxicam was statistically significant but probably not of clinical significance, 
since the bleeding time was on the upper limit of 10 min in all patients.  
In caesarean section, the potentiation of the side effects of the drug with 
pregnancy is considered and for this reason we excluded pregnant ladies.  
The number of patients undergoing tonsillectomy in Marret’s text is too small for 
analysis of site bleeding. The position in respect of major side effects, which are 
rare, is less reassuring. Some 60,000 patients per group would be required to 
show a statistically significant difference for the incidence of renal failure or 
major gastric bleeding between patients receiving NSAID and placebo. This 
finding is testimony to the importance of large, placebo-controlled, double-blind 
studies in defining the side effects of any drug. 
Hallucinations, anxiety and delirium were not encountered in the study. This in 
contrast to what is reported by Heintz (28) who attributed these to NSAIDs 
including tenoxicam but in line with what is reported by Caughey (31) who 
declared that neurological and psychiatric phenomena are not side effects of 
perioperative tenoxicam in relatively short courses. 
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4.2 Conclusion 
1. This is a controlled open study proved that preoperative intravenous 40 
mg tenoxicam is efficient in acute pain relief following ano-rectal 
surgeries. The postoperative pain was measured by visual analogue scale, 
verbal comment, and laddered colour category, face description, 
postoperative pleasure and mobility.  
2. The effective measure to postoperative ano-rectal pain is the serial 
assessment of its severity. Intravenous tenoxicam is efficient in alleviating 
this pain and minimizing the requirement of opioids.  
3. It was tolerated by the patients and showed no significant adverse effects 
of other non-steroidal anti-inflammatory drugs. 
4. The VAS is a universal tool for measurement of pain and can be used even 
in un-educated patients as shown in this study 
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4.3 Recommendations 
1. Close regular postoperative pain assessment following ano-rectal surgery 
using any measure tool. The study proved this was of a reliable verbal 
estimation and can be used.  
2. The usage of preoperative tenoxicam is recommended in a dose of 40 mg 
for adult patients with ano-rectal conditions.  
3. It is recommended to avoid the drug in patients with gastrointestinal 
bleeding and renal problems whom were excluded from the study. 
4. It is pertinent to suggest the use of VAS in ITU and when the 
postoperative pain is expected. It is a simple, sensitive, accurate and 
objective mode of assessment. The degree of activity and verbal 
comments are not always reliable. 
5. Future studies are also recommended for preoperative intravenous and 
intra-operative topical tenoxicam for patients with minor surgical 
procedures and day case surgery. 
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Figure (1): Distribution of patients in the study 
group according to admission route  
(n=163)  
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Figure (2): The gender distribution of the study group 
(n=163)  
 
 
 
 
 
 
 
Figure (3): Distribution of patients in the study 
group according to occupation  
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Figure (4): Distribution of the study group according 
to socio-economic status  
(n=163) 
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Figure (5): Postoperative pain assessment at 24 hours 
according to socio-economic status  
(n=163) 
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Figure (6): Distribution of patients the study 
group according to previous surgical 
intervention 
(n=163)  
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Figure (7): Postoperative pain assessment at 24 
hours according to previous surgical intervention 
(n=163) 
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Figure (8): Postoperative pain assessment at 24 hours 
according to educational levels of patients in the 
study group 
(n=163) 
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Figure (9): Postoperative pain assessment at 24 hours 
according to the type of ano-rectal conditions. 
(n=163) 
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Table (1): The educational levels of patients in the 
study group (n=163) 
Educational Level No. % 
Illiterate 51 31.3 
Khalwa 5 3.1 
Primary 12 7.4 
Intermediate  21 12.9 
Secondary  50 30.7 
University 17 10.4 
Postgraduate  7 4.3 
Total 163 100 
 
Table (2): The types of ano-rectal conditions 
encountered in patients in the study group (n=163) 
Diagnosis No. % 
Fistula In Ano 28 17.2% 
Haemorrhoids 35 20.9% 
Fissure In Ano 59 63.2% 
Perianal/submucous Abscesses 17 10.4% 
Ano-rectal Tumours 24 15.3% 
Total 163 100% 
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Table (3): Distribution of the study group according 
to the admission route (n=163) 
 
(P value = 0.66, sly insignificant) 
 
KEY 
 
OPD = OUTPATIENT DISCHARGE CLINIC 
A&E D = ACCIDENT EMERGENCY DEPARTMENT 
 
 
 
P value = 0.662, statistically insignificant) 
 
 
 
 
 
 
 
53 34 87
60.9% 39.1% 100.0%
37 39 76
48.7% 51.3% 100.0%
87 72 163
53.4% 44.2% 100.0%
No.
% 
No.
% 
No.
% 
 
T GROUP 
 
P GROUP 
 
 
Group 
Total 
OPD A&E 
Admission Route 
Total
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65 19 3 87
74.7% 21.8% 3.4% 100.0%
46 24 1 5 76
60.5% 31.6% 1.3% 6.6% 100.0%
111 43 1 8 163
68.1% 26.4% .6% 4.9% 100.0%
No. 
% 
No. 
% 
No. 
% 
T Group 
P Group 
  
Group 
                     Total 
0 - 3 3.1 - 5 5.1 - 7 7.1 - 10 
VAS Measurements at Zero Time Total
 
 
Table (4): Comparison of pain scores, using VAS 
measures, at zero time between T and P groups (n=163) 
 
 (P value = 0.202, statistically insignificant) 
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83 2 .00        2* 87
95.4% 2.3% .00 2.3% 100.0%
52 12 4        8* 76
68.4% 15.8% 5.3% 10.5% 100.0%
135 14 4 10 163
82.8% 8.6% 2.5% 6.1% 100.0%
No. 
% 
No. 
% 
No. 
% 
T  T Group 
 
P Group 
Group 
Total 
0 - 3 3.1 - 5 5.1 - 7 7.1 - 10 
VAS Measurement (in cm) at Eight 
Hours postoperatively 
Total
 
Table (5): Comparison of pain scores, using VAS 
measures at eight hours postoperatively between T and 
P groups  
(n=163) 
 
 
 
 
(P value = 0.0001, statistically significant) 
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Table (6): Comparison of pain scores, using VAS 
measures at 24 hours postoperatively between T and P 
groups (n=163) 
 
 
 
 
 
(P value = 0.0001, statistically significant) 
 
 
 
 
 
 
 
 
 
 
 
 
 
        81* 1 5 87
93.1% 1.1% 5.7% 100.0%
        50* 10 12 4 76
65.8% 13.2% 15.8% 5.3% 100.0%
131 11 17 4 163
80.4% 6.7% 10.4% 2.5% 100.0%
No. 
% 
No. 
% 
No. 
% 
GROUP 
Total 
0 - 3 3.1 - 5 5.1 - 7 7.1 - 10
VAS Measurements (in cm) AT 24
Hours Postoperatively 
Total
 T GROUP 
 P GROUP 
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Table (7): Comparison of pain assessment, using colour 
category, at 24 hours postoperatively between T and P 
groups (n=163) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (P value = 0.0001, statistically significant) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      81* 4 1       1* 87
93.1% 4.6% 1.1% 1.1% 100.0%
     31* 23 6       16* 76
40.8% 30.3% 7.9% 21.1% 100.0%
112 27 7 17 163
68.7% 16.6% 4.3% 10.4% 100.0%
No. 
% 
No. 
% 
No. 
% 
T Group 
P Group 
Group 
Total 
   Green Yellow Orange Red 
Colour Category at 24 Hours 
Postoperatively
Total
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50 14 23 87
57.5% 16.1% 26.4% 100.0%
25 32 14 5 76
32.9% 42.1% 18.4% 6.6% 100.0%
75 46 14 28 163
46.0% 28.2% 8.6% 17.2% 100.0%
No. 
% 
No. 
% 
No. 
% 
T Group 
P Group 
Group 
Total 
A B C D 
Face Description at 24 Hours Postoperatively
Total
 
Table (8): Comparison of face description at 24 hours 
postoperatively between T and P groups (n=163) 
 
 
 
 
 
 (P value = 0.0001, statistically significant) 
 
 
 
KEY 
• A = Normal face  
• B = Alert face 
• C = Frowning face 
• D = Apprehensive face 
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Table (9): Comparison of verbal pain assessment at 24 
hours postoperatively between T and P groups  
(n=163) 
 
 
 
 
 
 
 
 
 
(P value = 0.0001, statistically significant) 
 
KEY 
• Mild = discomfort on the site of the operation  
• Moderate = quite bad  
• Severe = very bad  
 
 
 
64 18 5 87
73.5% 20.7% 5.7% 100.0%
29 27 20 76
38.2% 35.5% 26.3% 100.0%
93 45 25 163
49.7% 27.6% 15.3% 100.0%
No. 
% 
No. 
% 
No. 
% 
T Group 
P Group 
Group 
Total 
Mild Moderate Severe 
Verbal Comment at 24 Hours
Postoperatively 
Total
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Table (10): Comparison of pleasure at 24 hours 
postoperative between T and P groups (n=163) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(P value = 0.0001, statistically significant) 
KEY 
• v.unsat: Very unsatisfactory = The very worst quality 
• unsat  :Unsatisfactory= Poor or not good enough 
• sat    :Satisfactory = Expectations were acceptable 
• plz    :Pleased = Willing and glad 
• v.plz  :Very pleased = The very best quality 
 
 
 
      1* 8 32       46* 87
  1.1% 9.2% 36.8% 52.9% 100.0%
9       17* 24 21          5* 76
11.8% 22.4% 31.6% 27.6% 6.6% 100.0%
9 18 32 53 51 163
5.5% 11.0% 19.6% 32.5% 31.3% 100.0%
No. 
%
No. 
%
Number 
Percentage 
T Group 
P Group 
Group 
Total 
v. unsat unsat sat plz v. plz
Postoperative Satisfaction about Analgesia at 24 hrs
Total
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Table (11): Comparison of mobility at 24 hours 
postoperatively between T and P groups (n=163) 
 
 
 
 
 
 
 
 
 
(P value = 0.668, statistically insignificant) 
KEY 
• A = performing most of activities  
• B = Stopping some activities 
• C = disability with stopping normal activities 
• D = no control considered as class D 
 
 
 
 
62 3 5 17 87
71.3% 3.4% 5.7% 19.5% 100.0%
40 4 10 22 76
52.6% 5.3% 13.2% 28.9% 100.0%
102 7 15 39 163
62.6% 4.3% 9.2% 23.9% 100.0%
No.
%
No.
%
No.
%
T Group 
P Group 
Group 
Total 
A B C D 
Postoperative Mobility at 24 hr 
Total
 87
Table (12): Comparison between trial and placebo 
groups according to postoperative bleeding at 24 hours 
(n=163) 
 
 
  
 
 
 
 
 
 
 
 
(P value = 0.0001, statistically significant) 
 
 
 
KEY 
• minimal = wetted the dressing 
• moderate = associated with systemic symptoms & required a change of dressing  
• severe = required the administration of intravenous fluids or blood.   
 
 
       58* 13 16 87
66.6% 14.9% 18.4% 100.0%
         25* 26 25 76
32.9% 34.2% 32.9% 100.0%
83 39 41 163
50.9% 23.9% 25.2% 100.0%
No.
%
No.
%
No.
%
T Group 
P Group 
Group 
Total 
Minimal Moderate Severe 
Postoperative bleeding at 24 h 
Total
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Table (13): Comparison between trial and placebo 
groups according to presence of postoperative nausea 
at 24 hours (n=163) 
 
 
 (P value = 0.0001, statistically significant) 
 
 
 
Group
                50*                 37* 87
57.5% 42.5% 100.0%
                  12*                  64* 76
15.8% 84.2% 100.0%
62 101 163
38.0% 62.0% 100.0%
No. 
% 
No. 
% 
No. 
% 
T Group 
P Group 
Total 
Not Present Present 
Postoperative Bleeding at 24 h 
Total
 Group 
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Table (14): Comparison between trial and placebo 
groups according to presence of postoperative sedation 
at 24 hours (n=163) 
 
 
 
 
(P value = 0.0001, statistically significant) 
 
 
 
 
 
77                       10* 87
88.5% 11.5% 100.0%
31                       45* 76
40.8% 59.2% 100.0%
108 55 163
66.3% 33.7% 100.0%
No.
%
No.
%
No.
%
T Group 
P Group 
Group 
Total 
Not present Present 
Postoperative Sedation at 24 h 
Total
 90
Table (15): Comparison between trial and placebo 
groups according to analgesic requirements at 24 hours 
(n=163) 
 
 
 
 
 
 
 
(P value = 0.0001, statistically significant) 
 
 
 
 
 
 
 
 
         70*         12*        5* 87
80.5% 13.8% 5.7% 100.0%
         16*      24*
        
25* 10 1 76
21.1% 31.6% 32.9% 13.2% 1.3% 100.0%
86 36 30 10 1 163
52.8%22.1% 18.4% 6.1% .6% 100.0%
No. 
% 
No. 
% 
No. 
% 
T Group 
P Group 
Group 
Total 
Panadol
1 Gram
Pethidine
25 mg
Pethidine
50 mg
Pethidine 
75 mg 
Pethidine 
100 mg &
more 
Analgesic Drugs given in Doses 
Total
 91
 
 
 
 
 
 
 
 
 
 
 ﺳﻢ اﷲ اﻟﺮﺣﻤﻦ اﻟﺮﺣﻴﻢ
 1 .oN etalP
 ﺟﺎﻣﻌﺔ اﻟﺨﺮﻃﻮم
 ﻣﺴﺘﺸﻔﻲ ﺳﻮﺑﺎ اﻟﺠﺎﻣﻌﻲ
 ﻗﺴﻢ اﻟﺠﺮاﺣﺔ
 
 
 
  
 
ﻣﻄﻠﻘًﺎ و ﻓﻲ أﻗﺼﻲ اﻟﻴﺴﺎر أﺷﺪ أﻟﻢ  اﺧﺘﺮ ﻓﻴﻤﺎ ﻳﻠﻲ درﺟﺔ اﻹﺣﺴﺎس ﺑﺎﻷﻟﻢ ﻣﻊ ﻣﺮاﻋﺎة ﻋﻠﻲ أﻗﺼﻲ اﻟﻴﻤﻴﻦ ﻻ ﻳﻮﺟﺪ أﻟﻢ -1
   ﻣﻤﻜﻦ
  
 
                                                          *                            * 
 أﻟﻢ                                                                      أﻗﺼﻲ أﻟﻢ ﺪﻻ ﻳﻮﺟ
                                   
 
 : ﺗﺤﺴﻪاﻟﺬي اﻟﻤﻜﺎن اﻟﻤﻨﺎﺳﺐ ﺣﺴﺐ درﺟﺔ اﻷﻟﻢ ﻓﻲ ? ﺿﻊ ﻋﻼﻣﺔ -2
 
    
    
    
    
  
 
  :  ﺣﺪد درﺟﺔ اﻷﻟﻢ-3
  
  (ﻧﻬﺎﺋﻴًﺎ)ﻻ أﺣﺲ ﺑﺄي أﻟﻢ ﻣﻄﻠﻘًﺎ 
  
  أﺣﺲ ﺑﺄﻟﻢ ﺧﻔﻴﻒ
  
  (ﻣﺰﻋﺞ ﻧﻮﻋًﺎ ﻣﺎ)أﺣﺲ ﺑﺄﻟﻢ ﻣﺘﻮﺳﻂ 
  
  أﺣﺲ ﺑﺄﻟﻢ ﺷﺪﻳﺪ
  
أﺣﺲ ﺑﺄﻗﺼﻰ درﺟﺔ أﻟﻢ ﻓﻲ ﺗﻘﺪﻳﺮي  
  ( ﻟﻢ أﺣﺴﻪ ﻣﻦ ﻗﺒﻞ)
  
   
  :اﻟﻨﺸﺎط  ﺣﺪد درﺟﺔ -4
  
  اﻣﺎرس ﻧﺸﺎط ﻃﺒﻴﻌﻰ
  
  اﻗﻮم ﺑﻤﻌﻈﻢ اﻻﻧﺸﻄﻪ
  
  ﺗﻮﻗﻔﺖ ﻋﻦ ﻣﻌﻈﻢ اﻻﻧﺸﻄﻪ
  
  ﺗﻮﻗﻔﺖ ﻋﻦ اﻻﻧﺸﻄﻪ اﻟﻄﺒﻴﻌﻴﻪ
  
   ﻻ أﺗﺤﻜﻢ ﻓﻰ ﻗﻴﺎم ﺑﺎﻻﻧﺸﻄﻪ
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ﻣﻄﻠﻘًﺎ و ﻓﻲ أﻗﺼﻲ اﻟﻴﺴﺎر أﺷﺪ أﻟﻢ  اﺧﺘﺮ ﻓﻴﻤﺎ ﻳﻠﻲ درﺟﺔ اﻹﺣﺴﺎس ﺑﺎﻷﻟﻢ ﻣﻊ ﻣﺮاﻋﺎة ﻋﻠﻲ أﻗﺼﻲ اﻟﻴﻤﻴﻦ ﻻ ﻳﻮﺟﺪ أﻟﻢ -1
   ﻣﻤﻜﻦ
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 أﻟﻢ                                                                      أﻗﺼﻲ أﻟﻢ ﺪﻻ ﻳﻮﺟ
                                   
 
 : ﺗﺤﺴﻪاﻟﺬي اﻟﻤﻜﺎن اﻟﻤﻨﺎﺳﺐ ﺣﺴﺐ درﺟﺔ اﻷﻟﻢ ﻓﻲ ? ﺿﻊ ﻋﻼﻣﺔ -2
 
    
    
    
    
  
 
  :  ﺣﺪد درﺟﺔ اﻷﻟﻢ-3
  
  (ﻧﻬﺎﺋﻴًﺎ)ﻻ أﺣﺲ ﺑﺄي أﻟﻢ ﻣﻄﻠﻘًﺎ 
  
  أﺣﺲ ﺑﺄﻟﻢ ﺧﻔﻴﻒ
  
  (ﻣﺰﻋﺞ ﻧﻮﻋًﺎ ﻣﺎ)أﺣﺲ ﺑﺄﻟﻢ ﻣﺘﻮﺳﻂ 
  
  أﺣﺲ ﺑﺄﻟﻢ ﺷﺪﻳﺪ
  
أﺣﺲ ﺑﺄﻗﺼﻰ درﺟﺔ أﻟﻢ ﻓﻲ ﺗﻘﺪﻳﺮي  
  ( ﻟﻢ أﺣﺴﻪ ﻣﻦ ﻗﺒﻞ)
  
   
  :اﻟﻨﺸﺎط  ﺣﺪد درﺟﺔ -4
  
  اﻣﺎرس ﻧﺸﺎط ﻃﺒﻴﻌﻰ
  
  اﻗﻮم ﺑﻤﻌﻈﻢ اﻻﻧﺸﻄﻪ
  
  ﺗﻮﻗﻔﺖ ﻋﻦ ﻣﻌﻈﻢ اﻻﻧﺸﻄﻪ
  
  ﺗﻮﻗﻔﺖ ﻋﻦ اﻻﻧﺸﻄﻪ اﻟﻄﺒﻴﻌﻴﻪ
  
   ﻻ أﺗﺤﻜﻢ ﻓﻰ ﻗﻴﺎم ﺑﺎﻻﻧﺸﻄﻪ
  
   
  
  
  
  
  
  
  
  ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــزﻣﻦ اﻻﺧﺘﺒﺎر
  
 ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ اﺳﻢ اﻟﻤﺮﻳﺾ
  
Plate No. 3 
Face Description (A, B, C & D) 
 
 
 
